Phase 3 pivotal study of Epacadostat in Combination With Opdivo (nivolumab) in first-line non-small cell lung cancer across the spectrum of PD-L1 expression.
Phase of Trial: Phase III
Latest Information Update: 04 May 2017
At a glance
- Drugs Epacadostat (Primary) ; Nivolumab
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- 04 May 2017 According to an Incyte Corporation media release, this trial is expected to initiate in 2017.
- 07 Apr 2017 New trial record